Association of Thyroid Hormone Medication Adherence With Risk of Dementia
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgad447 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Saemi Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, South Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Hypothyroidism. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Themen: Demenz
Abstract (Originalsprache)
Context
Recent studies suggest that hypothyroidism is a risk factor for dementia. Based on existing literature, it is unclear if treatment or compliance to treatment is associated with decreased dementia risk in hypothyroidism patients.
Objective
To determine the association between thyroid hormone medication adherence and risk of dementia.
Methods
A population-based cohort study following patients with newly diagnosed hypothyroidism until incidence of dementia, death, or December 31, 2020, whichever came earliest. The study comprised 41 554 older adults age 50 and above with newly diagnosed hypothyroidism between 2004 and 2008 who underwent health screening. Risk of dementia was evaluated using multivariable-adjusted Cox proportional hazards regression.
Results
Among 5188 men (12.5%) and 36 366 (87.5%) women, 2120 cases of incident dementia were identified. After stratification of the participants according to the interquartile range of the medication possession ratio (MPR), the fourth quartile (highest adherence) showed a 14% lower risk of overall dementia compared with the first quartile (lowest adherence) (adjusted hazard ratio 0.86; 95% CI 0.76-0.97). No consistent association was observed between thyroid hormone medication adherence and vascular dementia. After a dichotomous stratification of the MPR, higher MPR (≥0.8) showed a lower risk of Alzheimer disease (adjusted hazard ratio 0.91; 95% CI 0.84-0.99) than lower MPR (<0.8).
Conclusion
Better adherence to thyroid hormone medication may be beneficial in preventing incident dementia, especially Alzheimer disease, in older adults with newly diagnosed hypothyroidism. Along with the resolution of hypothyroid symptoms and the reduction of cardiovascular risk factors, the reduction of dementia risk may be another potential benefit of thyroid hormone medication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, South Korea.
- Department of Medicine, Seoul National University College of Medicine, Seoul 03080, South Korea.
- Department of Biomedical Informatics, CHA University School of Medicine, Seongnam 13448, Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Korea.
- Department of Family Medicine, Seoul National University Hospital, Seoul 03080, Korea.
- Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 04514, South Korea.
ORCID-Profile: Joung Sik Son, Sang Min Park
Förderung
- National Research Foundation of Korea
Zitieren
APA
Han, S., Jeong, S., Choi, S., Park, S. J., Kim, K. H., Lee, G., Cho, Y., Son, J. S., & Park, S. M. (2023). Association of Thyroid Hormone Medication Adherence With Risk of Dementia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad447
Vancouver
Han S, Jeong S, Choi S, Park SJ, Kim KH, Lee G, et al. Association of Thyroid Hormone Medication Adherence With Risk of Dementia. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad447
BibTeX
@article{Han2023,
author = {Han, Saemi and Jeong, Seogsong and Choi, Seulggie and Park, Sun Jae and Kim, Kyae Hyung and Lee, Gyeongsil and Cho, Yoosun and Son, Joung Sik and Park, Sang Min},
title = {Association of Thyroid Hormone Medication Adherence With Risk of Dementia},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgad447}
}
EUVIMED